French pharmaceutical company said drug could treat COVID-19 patients after promising test results
A leading French pharmaceutical company said it could potentially treat 300,000 COVID-19 patients with the anti-malarial drug Plaquenil after what it described as “promising” test results.
Sanofi said it was ready to offer France millions of doses of Plaquenil, a spokesperson for the laboratory told AFP, adding that the group was ready to work with French health authorities “to confirm these results.”
The study on 24 patients with coronavirus using Plaquenil, a hydroxychloroquine molecule, which has also been used for decades for the treatment of autoimmune diseases like lupus or rheumatoid arthritis.
Six days after the start of taking Plaquenil, the virus had disappeared in three-quarters of those treated, said Professor Didier Raoult, who is director of the Institut Hospitalo-Universitaire de Marseille.
The French government said the clinical trials were “promising” and would be extended to more patients.
You may be interested
Thousands of refugees and illegal immigrants to be removed from apartments and hotels in Greecemakis - May 29, 2020
The Migration and Asylum Ministry announced the start of the operation on June 1, of the eviction of both legitimate…
Muslims to pray in front of Hagia Sophia to put pressure to revert historic site into a Mosquemakis - May 28, 2020
Muslim mosques in Turkey will be reopening from tomorrow, Friday, the day of the fall of Constantinople (Istanbul), with the…
Athens Open Air Film Festival promises unforgettable nights to movie loversPanos - May 28, 2020
The Athens Open Air Film Festival promises movie goers unforgettable cinematic experiences as the summer event organised for the tenth…